ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly net cash paid for acquisitions ($M) [legacy through FY2022] ($M)
Quarterly figures from Eli Lilly's filings and investor materials
Latest, Q4 2022
327
Period ended Dec 31, 2022
Change on a year earlier
–
-0 in Q4 2021
History
49 quarters
Since Q4 2008
Sources
44
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Eli Lilly Net cash paid for acquisitions ($M) [legacy through FY2022] ($M), quarterly Q4 2008–Q4 2022 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_acq_cf
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.